The association of bullous pemphigoid with cerebrovascular disease and dementia: A case-control study

Archives of Dermatology

Volumn 146, Issue 11, 2010, Pages 1251-1254

  Taghipour, Kathy ^a   Chi, Ching Chi ^c   Vincent, Angela ^a   Groves, Richard W ^d   Venning, Vanessa ^a   Wojnarowska, Fenella ^b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; DEMENTIA; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PEMPHIGOID, BULLOUS;

EID: 78349285978     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.322     Document Type: Article

References (22)

1. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:a180.
2. Bertram F, Brocker EB, Zillikens D, Schmidt E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges. 2009;7(5):434-440.
3. Bernard P, Vaillant L, Labeille B, et al; Bullous Diseases French Study Group. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol. 1995;131(1):48-52.
4. Kirtschig G, Walkden VM, Venning VA, Wojnarowska F. Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature. Clin Exp Dermatol. 1995;20(6):449-453.
5. Stinco G, Codutti R, Scarbolo M, Valent F, Patrone P. A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases. Acta Derm Venereol. 2005;85(2):136-139.
6. Stinco G, Mattighello P, Zanchi M, Patrone P. Multiple sclerosis and bullous pemphigoid: a casual association or a pathogenetic correlation? Eur J Dermatol. 2002;12(2):186-188.
7. Foureur N, Descamps V, Lebrun-Vignes B, et al. Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? Eur J Dermatol. 2001;11(3):230-233.
8. Chosidow O, Doppler V, Bensimon G, et al. Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease? Arch Dermatol. 2000;136(4):521-524.
9. Dickmann U, Ritter G, Kretzschmar H. Pemphigoid and cerebral infarct: syntropy of 2 diseases? case report [in German]. Nervenarzt. 1986;57(5):309-310.
10. Forschner A, Ulmer A, Rassner G, Fierlbeck G. Bullous pemphigoid in a patient with Parkinson's disease. Eur J Dermatol. 2002;12(6):615.
11. Brown A, Bernier G, Mathieu M, Rossant J, Kothary R. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet. 1995;10(3):301-306.
12. Seppänen A, Suuronen T, Hofmann SC, Majamaa K, Alafuzoff I. Distribution of collagen XVII in the human brain. Brain Res. 2007;1158:50-56.
13. Cordel N, Chosidow O, Hellot MF, et al; French Study Group of Bullous Diseases. Neurological disorders in patients with bullous pemphigoid. Dermatology. 2007;215(3):187-191.
14. Wojnarowska F, Kirtschig G, Highet AS, Venning VA, Khumalo NP; British Association of Dermatologists. Guidelines for the management of bullous pemphigoid. Br J Dermatol. 2002;147(2):214-221.
15. Crooks V, Waller S, Smith T, Hahn TJ. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol. 1991;46(4):M139-M144.
16. Li L, Chen J, Wang B, Yao Y, Zuo Y. Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain. Br J Dermatol. 2009;160(6):1343-1345.
17. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain. 2000;123(pt 4):665-676.
18. Prettyman R. Extrapyramidal signs in cognitively intact elderly people. Age Ageing. 1998;27(5):557-560.
19. Claudepierre T, Manglapus MK, Marengi N, et al. Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system. J Comp Neurol. 2005;487(2):190-203.
20. Laffitte E, Burkhard PR, Fontao L, et al. Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis? Br J Dermatol. 2005;152(3):537-540.
21. Seppänen A, Autio-Harmainen H, Alafuzoff I, et al. Collagen XVII is expressed in human CNS neurons. Matrix Biol. 2006;25(3):185-188.
22. Young KG, Kothary R. Dystonin/Bpag1 is a necessary endoplasmic reticulum/nuclear envelope protein in sensory neurons. Exp Cell Res. 2008;314(15):2750-2761.